Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Self sample tests for cervical cancer could be ‘a game changer’

A non-invasive test to detect cervical pre-cancer by analysing urine and vaginal samples collected by women themselves is likely to improve participation in cervical cancer screening programmes.

A non-invasive test to detect cervical pre-cancer by analysing urine and vaginal samples collected by women themselves is likely to improve participation in cervical cancer screening programmes according to a new study. The study, presentated at the 2019 NCRI Cancer Conference, is the largest to test a methylation classifier, called S5, in urine and self-collected cervical samples to detect pre-cancer lesions in women who have been referred for further investigation.  Cervical cancer is the fourth most frequently occurring cancer in women in the world. In 2018, there were an estimated 570,000 new cases of cervical cancer and 310,000 women died from the disease. Infection with

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy